Hannah Kuchler

Lawsuit claims UK pharma giant understated the risk of government investigations

BioArctic is developing a process to allow drugs to cross the layer of cells that protects the brain

Anthos Therapeutics was set up by Blackstone Life Sciences after it licensed abelacimab drug from Novartis in 2019

UK pharma group raises long-term annual sales forecast to more than £40bn by 2031

Danish pharma group expects sales growth to slow this year

Pharma groups say higher levy will stifle growth of life sciences

Sector knocked by disappointing sales, an unexpected trial result and questions about the size of the market

Arrest of FTSE 100 pharma group’s country president last year is expected to hit sales

Sales figures for Mounjaro and Zepbound spook investors in world’s biggest drugmaker

Wellbeing of billions could be hit if administration cuts funding and spurns scientific best practice